Related Experiment Video
Updated: Oct 4, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
The role of splicing factor PRPF8 in breast cancer
Difei Cao1, Jiaying Xue1, Guoqing Huang1
1Institute of Advanced Technology, Heilongjiang Academy of Sciences, Harbin, Heilongjiang, China.
Background:
Alternative splicing is a mechanism to produce different proteins with diverse functions from one gene. Many splicing factors play an important role in cancer progression. PRPF8 is a core protein component of the spliceosome complex, U4/U6-U5 tri-snRNP.
Objective:
However, PRPF8 involved in mRNA alternative splicing are rarely included in the prognosis.
Methods:
We found that PRPF8 was expressed in all examined cancer types. Further analyses found that PRPF8 expression was significantly different between the breast cancer and paracancerous tissues.
Results:
Survival analyses showed that PRPF8-high patients had a poor prognosis, and the expression of PRPF8 is associated with distant metastasis-free survival (DMFS) and post progression survival (PPS). Gene Set Enrichment Analysis (GSEA) has revealed that PRPF8 expression is correlated with TGF-β, JAK-STAT, and cell cycle control pathways. Consistent with these results, upon PRPF8 silencing, the growth of MCF-7 cells was reduced, the ability of cell clone formation was weakened, and p21 expression was increased.
Conclusions:
These results have revealed that PRPF8 is a significant factor for splicing in breast cancer progression.
Insights
High PRPF8 expression indicates poor prognosis in breast cancer, impacting survival and metastasis. This splicing factor influences key cancer pathways and cell growth, highlighting its role in disease progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Alternative splicing generates protein diversity from single genes.
- Splicing factors are implicated in cancer development.
- PRPF8 is a crucial component of the spliceosome complex.
Purpose of the Study:
- To investigate the prognostic significance of PRPF8 in cancer.
- To explore the role of PRPF8 in breast cancer progression and survival.
Main Methods:
- Analysis of PRPF8 expression across various cancer types.
- Comparison of PRPF8 levels in breast cancer versus adjacent tissues.
- Survival analysis, including distant metastasis-free survival (DMFS) and post-progression survival (PPS).
- Gene Set Enrichment Analysis (GSEA) to identify associated pathways.
- In vitro experiments involving PRPF8 silencing in MCF-7 cells.
Main Results:
- PRPF8 is expressed in all tested cancer types.
- Significantly different PRPF8 expression observed between breast cancer and paracancerous tissues.
- High PRPF8 expression correlates with poor prognosis, reduced DMFS, and PPS.
- GSEA revealed PRPF8 expression is linked to TGF-β, JAK-STAT, and cell cycle pathways.
- PRPF8 silencing in MCF-7 cells reduced cell growth, colony formation, and increased p21 expression.
Conclusions:
- PRPF8 is a significant prognostic factor in breast cancer.
- PRPF8 plays a critical role in breast cancer progression.
- Targeting PRPF8 may offer therapeutic potential for breast cancer.
Related Concept Videos
RNA Splicing
Pre-mRNA Processing: RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Restarting Stalled Replication Forks
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Chromatin Structure and RNA Splicing

